<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146216">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01803386</url>
  </required_header>
  <id_info>
    <org_study_id>EIM-002-2011-4</org_study_id>
    <secondary_id>2R44NS070385-02A1</secondary_id>
    <nct_id>NCT01803386</nct_id>
  </id_info>
  <brief_title>Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography</brief_title>
  <official_title>Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance Myography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Skulpt, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Skulpt, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this protocol is to test a new Electrical Impedance Myography (EIM) device
      and study its reliability and ability to differentiate ALS patients from healthy controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators will study 10 ALS patients and at least 10 age-matched healthy controls
      between the ages of 21 and 85 years old. For all subjects, EIM measurements will be
      performed on four muscles: two in the upper and two in the lower extremities, using 8
      different EIM sensors. Measurements will be repeated one time.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Muscle health as captured by EIM measurements</measure>
    <time_frame>One time visit - Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>EIM measurements will be performed with several electrode arrays at one visit per patient. The data captured from ALS and healthy subjects will be used to refine and finalize electrode array design development for the EIM system.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Amyotrophic Lateral Sclerosis (ALS)</condition>
  <arm_group>
    <arm_group_label>ALS Subjects</arm_group_label>
    <description>EIM measurements will be taken on two upper and two lower extremity muscles with several different electrode arrays. The ALSFRS-R will also be administered. Subcutaneous fat measurement will also be performed on all four muscles using skinfold calipers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Subjects</arm_group_label>
    <description>EIM measurements will be taken on two upper and two lower extremity muscles with several different electrode arrays. Subcutaneous fat measurement will also be performed on all four muscles using skinfold calipers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EIM Measurements</intervention_name>
    <description>EIM measurements are taken by applying saline to the skin and placing a sensor on patients' muscles that will record electrical activity. Electrical current is generated by this machine, but patients will not be able to feel it. The electrical activity recorded is returned to the machine and analyzed by a computer.</description>
    <arm_group_label>ALS Subjects</arm_group_label>
    <arm_group_label>Healthy Subjects</arm_group_label>
    <other_name>Electrical Impedance Myography Measurements</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        ALS Patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of probable or definite ALS by the El Escorial Criteria

        Exclusion Criteria:

          -  History of superimposed generalized neuromuscular disease

          -  Primary lateral sclerosis or other atypical motor neuron disorders

          -  Forced vital capacity of less than 50%

          -  Presence of disease for greater than 5 years since symptom onset
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erik Ensrud, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Boston Healthcare System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Freedman, MSN</last_name>
    <phone>888.382.8824</phone>
    <phone_ext>108</phone_ext>
    <email>musclestudy@cmdevices.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jose Bohorquez, PhD</last_name>
    <phone>888.382.8824</phone>
    <phone_ext>100</phone_ext>
    <email>musclestudy@cmdevices.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Convergence Medical Devices</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Freedman, MSN</last_name>
      <phone>888-382-8824</phone>
      <phone_ext>108</phone_ext>
      <email>musclestudy@cmdevices.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.cmdevices.com</url>
    <description>Convergence Medical Devices Website</description>
  </link>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 1, 2013</lastchanged_date>
  <firstreceived_date>February 28, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ALS</keyword>
  <keyword>EIM</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Neuromuscular Diseases</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
